Table 3.
Outcome effect | Estimate [95% CI] | p | adj. pa | gc |
---|---|---|---|---|
Circulating PACAP [pM, log-transformed] | ||||
Genotype CC vs. other | 0.07 [−0.04, 0.18] | 0.20 | 0.27 | |
Female | −0.07 [−0.17, 0.03] | 0.16 | −0.33 | |
Genotype CC vs. other in men | 0.07 [−0.10, 0.25] | 0.42 | 0.30 | |
Genotype CC vs. other in women | 0.07 [−0.06, 0.19] | 0.28 | 0.24 | |
Genotype CC vs. other differenceb | 0.00 [−0.21, 0.22] | 0.98 | n/a | |
PTSD lifetime diagnosis | −0.02 [−0.26, 0.23] | 0.88 | −0.13 | |
Total anxiety symptom severity (HAM-A total scores) | ||||
Genotype CC vs. other | 0.58 [−2.02, 3.18] | 0.66 | 0.66 | 0.26 |
Female | −0.08 [−2.47, 2.30] | 0.94 | 0.94 | −0.11 |
Genotype CC vs. other in men | −0.95 [−5.29, 3.39] | 0.66 | 0.66 | −0.25 |
Genotype CC vs. other in women | 2.11 [−0.77, 4.99] | 0.15 | 0.22 | 0.53 |
Genotype CC vs. other differenceb | −3.06 [−8.26, 2.14] | 0.25 | 0.37 | n/a |
PTSD lifetime diagnosis | 1.21 [−4.45, 6.88] | 0.67 | 0.80 | 0.18 |
Psychological anxiety symptom severity (HAM-A psychological scores) | ||||
Genotype CC vs. other | 1.00 [−0.91, 2.90] | 0.30 | 0.66 | 0.28 |
Female | −0.89 [−2.64, 0.86] | 0.31 | 0.47 | −0.31 |
Genotype CC vs. other in men | 1.10 [−2.08, 4.27] | 0.49 | 0.66 | 0.18 |
Genotype CC vs. other in women | 0.90 [−1.21, 3.00] | 0.40 | 0.40 | 0.34 |
Genotype CC vs. other differenceb | 0.20 [−3.61, 4.01] | 0.92 | 0.92 | n/a |
PTSD lifetime diagnosis | 0.89 [−3.26, 5.04] | 0.67 | 0.80 | 0.08 |
Somatic anxiety symptom severity (HAM-A somatic scores) | ||||
Genotype CC vs. other | −0.41 [−1.66, 0.84] | 0.51 | 0.66 | 0.12 |
Female | 0.80 [−0.35, 1.94] | 0.17 | 0.47 | 0.25 |
Genotype CC vs. other in men | −2.05 [−4.12, 0.03] | 0.05 | 0.16 | −1.00 |
Genotype CC vs. other in women | 1.22 [−0.16, 2.60] | 0.08 | 0.22 | 0.62 |
Genotype CC vs. other differenceb | −3.27 [−5.76, −0.77] | 0.01 | 0.03 | n/a |
PTSD lifetime diagnosis | 0.35 [−2.37, 3.07] | 0.80 | 0.80 | 0.26 |
Sleep quality (PSQI global scores) | ||||
Genotype CC vs. other | 0.73 [−0.62, 2.08] | 0.28 | 0.66 | |
Female | −0.29 [−1.45, 0.87] | 0.62 | −0.15 | |
Genotype CC vs. other in men | 0.35 [−2.08, 2.79] | 0.77 | 0.07 | |
Genotype CC vs. other in women | 1.11 [−0.05, 2.27] | 0.06 | 0.81 | |
Genotype CC vs. other differenceb | −0.75 [−3.45, 1.94] | 0.58 | n/a | |
PTSD lifetime diagnosis | 3.24 [0.99, 5.49] | 0.01 | 1.07 |
Genotypes are PAC1R SNP (rs2267735) genotypes, and effects shown are based on specific contrasts between estimated marginal means estimated within a single generalized linear model for each outcome
aadj. p = adjusted for false discovery rate among HAM-A total and subscales only
bDifference refers here to the sex difference in the CC vs. other (CG and GG) genotype effect (i.e., the interaction of gender and genotype effects)
cHedges’ g effect size of group differences based on raw means